Coloplast A/S (OTCMKTS:CLPBY) Sees Strong Trading Volume – Time to Buy?

Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY) shares saw unusually-strong trading volume on Monday . Approximately 847,664 shares were traded during mid-day trading, an increase of 47% from the previous session’s volume of 575,459 shares.The stock last traded at $6.36 and had previously closed at $6.30.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on CLPBY shares. Sanford C. Bernstein upgraded Coloplast A/S to a “hold” rating in a research note on Wednesday, January 28th. The Goldman Sachs Group lowered shares of Coloplast A/S from a “hold” rating to a “strong sell” rating in a research note on Tuesday, April 7th. One analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Reduce”.

Coloplast A/S Stock Up 0.5%

The firm’s 50 day simple moving average is $6.81 and its 200 day simple moving average is $8.04. The company has a market cap of $14.27 billion, a price-to-earnings ratio of 23.45, a price-to-earnings-growth ratio of 2.03 and a beta of 0.15. The company has a quick ratio of 0.81, a current ratio of 1.30 and a debt-to-equity ratio of 1.50.

Coloplast A/S (OTCMKTS:CLPBY) last announced its quarterly earnings results on Friday, February 6th. The company reported $0.10 EPS for the quarter, beating the consensus estimate of $0.09 by $0.01. Coloplast A/S had a net margin of 14.35% and a return on equity of 27.87%. The company had revenue of $1.11 billion for the quarter, compared to analyst estimates of $1.12 billion. Sell-side analysts anticipate that Coloplast A/S Sponsored ADR will post 0.39 EPS for the current fiscal year.

About Coloplast A/S

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.